Safety of PATANASE Nasal Spray in Patients With Perennial Allergic Rhinitis

PHASE4CompletedINTERVENTIONAL
Enrollment

1,260

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Perennial Allergic Rhinitis
Interventions
DRUG

Olopatadine hydrochloride 0.6% nasal spray (PATANASE)

Two sprays in each nostril twice a day (morning and evening) for up to 12 months

OTHER

Olopatadine nasal spray vehicle, pH 3.7

Two sprays in each nostril twice a day (morning and evening) for up to 12 months

OTHER

Olopatadine nasal spray vehicle, pH 7.0

Two sprays in each nostril twice a day (morning and evening) for up to 12 months

Trial Locations (1)

76134

Contact Alcon Call Center For Trial Locations, Fort Worth

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Alcon Research

INDUSTRY